Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
09/06/2002 | WO2002068367A1 A method to inhibit ethylene responses in plants |
09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
09/06/2002 | WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
09/06/2002 | WO2002030558A3 A linker and a method of chemical synthesis |
09/06/2002 | WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
09/06/2002 | WO2001090071A3 Substituted iminoazines used as herbicides |
09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
09/06/2002 | CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
09/05/2002 | US20020123633 Reacting an alpha -picoline or gamma -picoline with formaldehyde in vapor phase in presence of metal cation modified zeolite MFI or zeolite zeolite MEL to produce 2-vinylpyridine or 4-vinylpyridine compound |
09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
09/05/2002 | US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC |
09/05/2002 | US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol |
09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
09/05/2002 | US20020123496 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
09/05/2002 | US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
09/05/2002 | US20020123492 Beta-amino acid derivatives |
09/05/2002 | US20020121638 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
09/04/2002 | EP1236717A1 Oxime o-ether compounds and fungicides for agricultural and horticultural use |
09/04/2002 | EP1236712A1 Amidinophenylpyruvic acid derivative |
09/04/2002 | EP1235824A1 Vitamin d analogues |
09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
09/04/2002 | EP1235805A2 Immunoassay for neonicotinyl insecticides |
09/04/2002 | EP1235788A1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
09/04/2002 | EP1235777A2 Vitamin d analogues |
09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
09/04/2002 | EP1080086B1 Dihydropyrimidines |
09/04/2002 | EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
09/04/2002 | EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
09/04/2002 | CN1367687A Calcilytic compounds |
09/04/2002 | CN1090182C Process for preparation of 5-substituted 2-chloropyridines |
09/04/2002 | CN1090177C Preparation of aromatic nitriles |
09/04/2002 | CN1090176C Purification of nitrile |
09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
09/04/2002 | CN1090019C 组合物 The composition |
09/03/2002 | US6444820 Process for the manufacture of camptothecin derivatives |
09/03/2002 | US6444817 Anticoagulants |
09/03/2002 | US6444815 Method for producing heteroaromatic aldehydes |
09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
09/03/2002 | US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof |
09/03/2002 | US6444606 Supported catalyst system, method for the production and use thereof in olefin polymerization |
09/03/2002 | US6444279 Liquid crystal propene or propenyl nitrile derivatives |
09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
08/29/2002 | WO2002067053A2 High speed photothermographic materials containing tellurium compounds and methods of using same |
08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
08/29/2002 | WO2002066434A1 Oxime ether compound and agricultural or horticultural bactericide |
08/29/2002 | WO2002066433A1 Process and catalyst for the preparation of acetylpyridines |
08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
08/29/2002 | WO2002066430A1 Tryptase inhibitors |
08/29/2002 | WO2002066425A2 Compositions and methods for hydration of terminal alkynes |
08/29/2002 | WO2002066420A2 Tryptase inhibitors |
08/29/2002 | WO2002066418A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
08/29/2002 | WO2002066416A1 Method of synthesizing camptothecin-relating compounds |
08/29/2002 | WO2002066413A1 Flecainide synthesis |
08/29/2002 | WO2002066020A2 Modulation of gsk-3beta activity and its different uses |
08/29/2002 | WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
08/29/2002 | WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
08/29/2002 | WO2001017530A9 Iron chelators and uses thereof |
08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
08/29/2002 | US20020120147 Micronized torsemide |
08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
08/29/2002 | US20020119979 Cancer therapy |
08/29/2002 | US20020119968 Protease inhibitor |
08/29/2002 | US20020119960 Drug resistance therapy |
08/29/2002 | US20020119957 Novel post-amadori inhibitors of advanced glycation reactions |
08/29/2002 | US20020119955 Modified prodrug forms of AP/AMP |
08/29/2002 | US20020119953 Sickle cell anemia |
08/29/2002 | US20020119910 Drug delivery |
08/29/2002 | DE19941540C2 Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie Sulfonylcarboxamide for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia |
08/29/2002 | DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives |
08/29/2002 | CA2683768A1 Method of synthesizing camptothecin-relating compounds |
08/29/2002 | CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
08/29/2002 | CA2438711A1 Tryptase inhibitors |
08/29/2002 | CA2438685A1 Tryptase inhibitors |
08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
08/29/2002 | CA2437704A1 Process and catalyst for the preparation of acetylpyridines |
08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
08/28/2002 | EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
08/28/2002 | EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
08/28/2002 | EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
08/28/2002 | EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |